Bionano Genomics Lunch and Learn at Fred Hutchinson Cancer Research Center

You're invited! Please join us at our Bionano Genomics Lunch and Learn at Fred Hutchinson on Wednesday, February 19th from 1:30PM - 2:30PM.

Bionano Genomics Lunch and Learn at Fred Hutchinson Cancer Research Center
:

Wednesday, February 19th | 1:30 pm - 2:30 pm

Pelton Auditorium – Thomas Building

**********

You're Invited!

“Next-Generation Cytogenomics: High-throughput genome mapping of structural variation in cancer research and clinical oncology

Sven Bocklandt, PhD, Director of Scientific Affairs

The promise of personalized medicine in cancer remains elusive, because no single technology can comprehensively detect all the rearrangements in the cancer genome.

Bionano Genomics’ platform for genome imaging offers an extremely long-read technology, providing unmatched sensitivity and specificity to detect structural variation, genome-wide, at low cost. Our de novo maps can resolve complex repetitive regions, identify Copy Number Variations, and elucidate genome-wide structural variation like balanced/unbalanced translocations, inversions, and indels with much higher sensitivity and precision than sequencing-based methods. 

For heterogeneous cancer samples, Bionano’s extremely high coverage depth allows for the detection of any type of structural variant with more than 90% sensitivity, present in as little as 5% allele fraction, genome-wide, and completely unbiased.

Examples will be presented of how Bionano’s platform elucidates genomic rearrangements in cancer that are missed by NGS and cytogenetic methods, and how whole genome imaging may replace almost all karyotyping, FISH and CNV-microarray assays.

Lunch will be provided for guests who RSVP!

RSVP Now!

Questions? Please contact Heather Mashhoodi

hmashhoodi@bionanogenomics.com

For Research Use Only. Not for use in diagnostic procedures.

About Bionano Genomics

Bionano is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system comprises an instrument, chip consumables, reagents and a suite of data analysis tools.